Article
MRAS Variants Cause Cardiomyocyte Hypertrophy in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Additional Evidence for MRAS as a Definitive Noonan Syndrome-Susceptibility Gene.
Circulation. Genomic and precision medicine - 1 Nov 2019
Higgins Erin M, Bos J Martijn, Dotzler Steven M, John Kim C S, Ackerman Michael J
Abstract excerpt
BACKGROUND: MRAS was identified recently as a novel Noonan syndrome (NS)-susceptibility gene. Phenotypically, both patients with NS, harboring pathogenic MRAS variants, displayed severe cardiac hypertrophy. This study aimed to demonstrate both the necessity and sufficiency of a patient-specific variant (p.Gly23Val-MRAS) to cause NS through the generation and characterization of patient-specific, isogenic control,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.